Contrary to the traditional doctrine of delayed intervention in post-hysterectomy injuries of the ureter or bladder, the policy at our department has been to operate as soon as possible after the diagnosis is made. Of 68 patients (25 with vesicovaginal fistulas and 43 with ureteral injuries) early intervention was possible in 40 (59%). Primary healing was obtained in all patients. These results suggest that there is no disadvantage in early repair.
SUMMARY One hundred cases oftransitional cell carcinoma ofthe bladder were studied to determine whether squamous metaplasia and other histological features within the bladder can be of value in predicting outcome of treatment with radiotherapy. Sixty cases showed the changes of squamous metaplasia, and of this group 46 (78%) failed to respond to radiotherapy. A significant response rate of 90% was seen in the 40 tumours without squamous metaplasia.It is concluded that transitional cell carcinomas of the bladder showing squamous metaplasia are mainly resistant to radiotherapy and alternative treatment methods should be sought.The heterogeneity of invasive bladder carcinoma has prompted many studies of histological features in an attempt to relate these to prognosis.`13 Most studies have been performed on radical cystectomy specimens, and there is little information about the histological features in transurethral resection material which may be relevant to the prognosis of patients, especially those treated with radiotherapy.The presence of squamous metaplasia is well recognised in transitional cell carcinoma of the bladder,45 but its importance for prognosis is not known. It has been shown that squamous cell carcinoma of the bladder is more resistant to radiotherapy than its transitional cell counterpart,67 and this aroused our interest in the responsiveness to radiotherapy of transitional cell carcinomas showing squamous metaplasia.It has been suggested that if radioresponsiveness of the tumour could be predicted more accurately before irradiation then non-responders could be offered alternative treatment including early cystectomy. We therefore undertook a study to determine whether the histological features of invasive transitional cell carcinoma of the bladder were related to or could be used to predict the response of the tumour to radiotherapy. Material and methodsFrom the records of the departments of urology and histopathology at this hospital 111 patients with muscle invasive transitional cell carcinoma of the bladder were identified (International Union Against Cancer (UICC) and American (Jewett) classification Accepted for publication 6 October 1988 stage T2/T3).' These patients presented between 1980 and 1985 and had received radiotherapy. Six cases with invasion of the prostate (UICC stage 4) were excluded as this group is recognised as having a poor prognosis and as being resistant to radiotherapy.8 In five cases the original pathology material was unavailable, thus leaving 100 cases. The mean age of patients was 68 3 years, range 33-85. There were 78 men and 22 women.The histological sections were processed from tissue fixed in 10% formol saline by standard techniques and stained with haematoxylin and eosin. The original tumours before treatment had been reviewed independently by three pathologists (JM, RZ, SB) unaware of the clinical outcome. Between one and seven blocks of tissue were available in each case (mean 2.6).The sections were assessed for grade using the WHO classification,5 degree and...
In a review of 1057 consecutive prostatectomies of which 95% were performed transurethrally, carcinoma was present in 11.8%. There were 10 deaths within a month of operation (0.9%), 9 of these patients having been exceptionally old and unfit. The rate of complications and the end results appear to justify using transurethral resection as the method of choice for prostatectomy whenever it is feasible.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.